ReviewFrontiers in pharmacology2020

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases.

Jonathan E PhillipsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.